Medical Futurist September 28, 2019

The number of people having their genomes sequenced could reach more than 100 million by 2025, researchers estimated. Policy-makers around the world started to realize the incredible potential in genomics for population health in the last 3-5 years, but there are huge question marks whether they can manage the use of this incredibly useful pool of data in an appropriate framework, with well-thought-out means, for the right purposes, meaning for the well-being of humans and communities in the present and the future. Here, we launched an article series to look at the countries with the most experience. Let’s start with a truly positive example: the fairytale from the digital republic: Estonia.

Your whole-genome sequenced as a holiday special for $200?

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Patient / Consumer, Precision Medicine, Provider, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article